BIXT
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
8.9M
BZYR
Price
$0.06
Change
+$0.02 (+66.67%)
Updated
Jul 1 closing price
Capitalization
7.23M
Interact to see
Advertisement

BIXT vs BZYR

Header iconBIXT vs BZYR Comparison
Open Charts BIXT vs BZYRBanner chart's image
Bioxytran
Price$0.10
Change-$0.00 (-0.00%)
Volume$21.09K
Capitalization8.9M
Burzynski Research Institute
Price$0.06
Change+$0.02 (+66.67%)
Volume$1K
Capitalization7.23M
BIXT vs BZYR Comparison Chart in %
Loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BZYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIXT vs. BZYR commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIXT is a Hold and BZYR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (BIXT: $0.10 vs. BZYR: $0.05)
Brand notoriety: BIXT and BZYR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIXT: 14% vs. BZYR: 19%
Market capitalization -- BIXT: $8.9M vs. BZYR: $7.23M
BIXT [@Biotechnology] is valued at $8.9M. BZYR’s [@Biotechnology] market capitalization is $7.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIXT’s FA Score shows that 0 FA rating(s) are green whileBZYR’s FA Score has 0 green FA rating(s).

  • BIXT’s FA Score: 0 green, 5 red.
  • BZYR’s FA Score: 0 green, 5 red.
According to our system of comparison, BZYR is a better buy in the long-term than BIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIXT’s TA Score shows that 3 TA indicator(s) are bullish while BZYR’s TA Score has 4 bullish TA indicator(s).

  • BIXT’s TA Score: 3 bullish, 5 bearish.
  • BZYR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BZYR is a better buy in the short-term than BIXT.

Price Growth

BIXT (@Biotechnology) experienced а -10.63% price change this week, while BZYR (@Biotechnology) price change was +70.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BZYR is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIXT($8.9M) has a higher market cap than BZYR($7.23M). BZYR YTD gains are higher at: 77.419 vs. BIXT (11.235). BZYR has higher annual earnings (EBITDA): -1.46M vs. BIXT (-2.38M). BIXT has more cash in the bank: 4.35K vs. BZYR (613). BIXT (0) and BZYR (0) have equivalent revenues.
BIXTBZYRBIXT / BZYR
Capitalization8.9M7.23M123%
EBITDA-2.38M-1.46M163%
Gain YTD11.23577.41915%
P/E RatioN/AN/A-
Revenue00-
Total Cash4.35K613709%
Total Debt1.26MN/A-
FUNDAMENTALS RATINGS
BIXT vs BZYR: Fundamental Ratings
BIXT
BZYR
OUTLOOK RATING
1..100
5950
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6337
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIXT's Valuation (85) in the null industry is in the same range as BZYR (99). This means that BIXT’s stock grew similarly to BZYR’s over the last 12 months.

BIXT's Profit vs Risk Rating (100) in the null industry is in the same range as BZYR (100). This means that BIXT’s stock grew similarly to BZYR’s over the last 12 months.

BIXT's SMR Rating (99) in the null industry is in the same range as BZYR (100). This means that BIXT’s stock grew similarly to BZYR’s over the last 12 months.

BZYR's Price Growth Rating (37) in the null industry is in the same range as BIXT (63). This means that BZYR’s stock grew similarly to BIXT’s over the last 12 months.

BZYR's P/E Growth Rating (100) in the null industry is in the same range as BIXT (100). This means that BZYR’s stock grew similarly to BIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIXTBZYR
RSI
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
72%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
65%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BZYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRWD514.1018.00
+3.63%
CrowdStrike Holdings
ATRO32.630.10
+0.31%
Astronics Corp
STNE16.180.04
+0.25%
StoneCo Ltd
DRRX0.67N/A
+0.02%
DURECT Corp
AFCG4.70-0.02
-0.42%
Advanced Flower Capital Inc

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CCCC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
+1.88%
CCCC - BIXT
22%
Poorly correlated
-2.63%
IMUX - BIXT
22%
Poorly correlated
+1.99%
WVE - BIXT
20%
Poorly correlated
+2.96%
DOMH - BIXT
20%
Poorly correlated
+0.38%
BSEM - BIXT
11%
Poorly correlated
-0.42%
More

BZYR and

Correlation & Price change

A.I.dvisor tells us that BZYR and DWTX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BZYR and DWTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BZYR
1D Price
Change %
BZYR100%
N/A
DWTX - BZYR
29%
Poorly correlated
-0.62%
CRNX - BZYR
21%
Poorly correlated
+1.22%
RENB - BZYR
20%
Poorly correlated
+3.44%
BVNRY - BZYR
10%
Poorly correlated
+0.11%
BIXT - BZYR
1%
Poorly correlated
+1.88%
More